Mechanisms of progesterone action in inhibiting prematurity

References

• Hamilton B E, Martin J A, Ventura S J, Sutton P D, Menacker F. Births: Preliminary data for 2004. Natl Vital Stat Rep 2005; 54: 1–17
   Google Scholar
• Lopez Bernal A, Rivera J, Europe-Finner G N, Phaneuf S, Asboth G. Parturition: Activation of stimulatory pathways or loss of uterine quiescence?. Adv Exp Med Biol 1995; 395: 435–451
   PubMedGoogle Scholar
• Romero R, Avila C, Brekus C A, Morotti R. The role of systemic and intrauterine infection in preterm parturition. Ann N Y Acad Sci 1991; 622: 355–375
   PubMedGoogle Scholar
• Romero R, Emamian M, Wan M, Quintero R, Hobbins J C, Mitchell M D. Prostaglandin concentrations in amniotic fluid of women with intra-amniotic infection and preterm labor. Am J Obstet Gynecol 1987; 157: 1461–1467
   PubMed Web of Science ®Google Scholar
• Elovitz M A, Ascher-Landsberg J, Saunders T, Phillippe M. The mechanisms underlying the stimulatory effects of thrombin on myometrial smooth muscle. Am J Obstet Gynecol 2000; 183: 674–681
   PubMed Web of Science ®Google Scholar
• Elovitz M A, Baron J, Phillippe M. The role of thrombin in preterm parturition. Am J Obstet Gynecol 2001; 185: 1059–1063
   PubMed Web of Science ®Google Scholar
• Challis J R, Lye S J. Characteristics of parturition. Maternal-fetal medicine: Principles and practice, R K Creasy, R Reznick, J Iams. Saunders, Philadelphia, PA 2004
   Google Scholar
• Peyron R, Aubeny E, Targosz V, Silvestre L, Renault M, Elkik F, Leclerc P, Ulmann A, Baulieu E E. Early termination of pregnancy with mifepristone (RU 486) and the orally active prostaglandin misoprostol. N Engl J Med 1993; 328: 1509–1513
   PubMed Web of Science ®Google Scholar
• Challis J R, Matthews S G, Gibb W, Lye S J. Endocrine and paracrine regulation of birth at term and preterm. Endocr Rev 2000; 21: 514–550
   PubMed Web of Science ®Google Scholar
• Norwitz E R, Robinson J N, Challis J R. The control of labor. NEJM 1999; 341: 660–666
   PubMed Web of Science ®Google Scholar
• Johnson J W, Austin K L, Jones G S, Davis G H, King T M. Efficacy of 17alpha-hydroxyprogesterone caproate in the prevention of premature labor. N Engl J Med 1975; 293: 675–680
   PubMed Web of Science ®Google Scholar
• Yemini M, Borenstein R, Dreazen E, Apelman Z, Mogilner B M, Kessler I, Lancet M. Prevention of premature labor by 17 alpha-hydroxyprogesterone caproate. Am J Obstet Gynecol 1985; 151: 574–577
   PubMed Web of Science ®Google Scholar
• Hartikainen-Sorri A L, Kauppila A, Tuimala R. Inefficacy of 17 alpha-hydroxyprogesterone caproate in the prevention of prematurity in twin pregnancy. Obstet Gynecol 1980; 56: 692–695
   PubMed Web of Science ®Google Scholar
• Hauth J C, Gilstrap L C, 3rd, Brekken A L, Hauth J M. The effect of 17 alpha-hydroxyprogesterone caproate on pregnancy outcome in an active-duty military population. Am J Obstet Gynecol 1983; 146: 187–190
   PubMed Web of Science ®Google Scholar
• Keirse M J. Progestogen administration in pregnancy may prevent preterm delivery. Br J Obstet Gynaecol 1990; 97: 149–154
   PubMedGoogle Scholar
• Fuchs F, Stakemann G. Treatment of threatened premature labor with large doses of progesterone. Am J Obstet Gynecol 1960; 79: 172–176
   PubMed Web of Science ®Google Scholar
• Kauppila A, Hartikainen-Sorri A L, Janne O, Tuimala R, Jarvinen P A. Suppression of threatened premature labor by administration of cortisol and 17 alpha-hydroxyprogesterone caproate: A comparison with ritodrine. Am J Obstet Gynecol 1980; 138: 404–408
   PubMed Web of Science ®Google Scholar
• Erny R, Pigne A, Prouvost C, Gamerre M, Malet C, Serment H, Barrat J. The effects of oral administration of progesterone for premature labor. Am J Obstet Gynecol 1986; 154: 525–529
   PubMed Web of Science ®Google Scholar
• Tomasi A, Tseng H Y, Scommegna A, Burd L. The effect of medroxyprogesterone acetate on premature labor in the sheep. Am J Obstet Gynecol 1985; 151: 694–700
   PubMedGoogle Scholar
• Noblot G, Audra P, Dargent D, Faguer B, Mellier G. The use of micronized progesterone in the treatment of menace of preterm delivery. Eur J Obstet Gynecol Reprod Biol 1991; 40: 203–209
   PubMed Web of Science ®Google Scholar
• Meis P J, Klebanoff M, Thom E, Dombrowski M P, Sibai B, Moawad A H, Spong C Y, Hauth J C, Miodovnik M, Varner M W, et al. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 2003; 348: 2379–2385
   PubMed Web of Science ®Google Scholar
• da Fonseca E B, Bittar R E, Carvalho M H, Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: A randomized placebo-controlled double-blind study. Am J Obstet Gynecol 2003; 188: 419–424
   PubMed Web of Science ®Google Scholar
• Csapo A I, Pinto-Dantas C A. The effect of progesterone on the human uterus. Proc Natl Acad Sci USA 1965; 54: 1069–1076
   PubMed Web of Science ®Google Scholar
• Csapo A I, Pohanka O, Kaihola H L. Progesterone deficiency and premature labour. Br Med J 1974; 1: 137–140
   PubMedGoogle Scholar
• Cousins L M, Hobel C J, Chang R J, Okada D M, Marshall J R. Serum progesterone and estradiol-17beta levels in premature and term labor. Am J Obstet Gynecol 1977; 127: 612–615
   PubMedGoogle Scholar
• Kastner P, Krust A, Turcotte B, Stropp U, Tora L, Gronemeyer H, Chambon P. Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms A and B. Embo J 1990; 9: 1603–1614
   PubMed Web of Science ®Google Scholar
• Sartorius C A, Melville M Y, Hovland A R, Tung L, Takimoto G S, Horwitz K B. A third transactivation function (AF3) of human progesterone receptors located in the unique N-terminal segment of the B-isoform. Mol Endocrinol 1994; 8: 1347–1360
   PubMed Web of Science ®Google Scholar
• Pieber D, Allport V C, Hills F, Johnson M, Bennett P R. Interactions between progesterone receptor isoforms in myometrial cells in human labour. Mol Hum Reprod 2001; 7: 875–879
   PubMed Web of Science ®Google Scholar
• Giangrande P H, Kimbrel E A, Edwards D P, McDonnell D P. The opposing transcriptional activities of the two isoforms of the human progesterone receptor are due to differential cofactor binding. Mol Cell Biol 2000; 20: 3102–3115
   PubMed Web of Science ®Google Scholar
• Dong X, Challis J R, Lye S J. Intramolecular interactions between the AF3 domain and the C-terminus of the human progesterone receptor are mediated through two LXXLL motifs. J Mol Endocrinol 2004; 32: 843–857
   PubMedGoogle Scholar
• Haluska G J, Wells T R, Hirst J J, Brenner R M, Sadowsky D W, Novy M J. Progesterone receptor localization and isoforms in myometrium, decidua, and fetal membranes from rhesus macaques: Evidence for functional progesterone withdrawal at parturition. J Soc Gynecol Investig 2002; 9: 125–136
   PubMedGoogle Scholar
• Mesiano S, Chan E C, Fitter J T, Kwek K, Yeo G, Smith R. Progesterone withdrawal and estrogen activation in human parturition are coordinated by progesterone receptor A expression in the myometrium. J Clin Endocrinol Metab 2002; 87: 2924–2930
   PubMed Web of Science ®Google Scholar
• Mesiano S. Myometrial progesterone responsiveness and the control of human parturition. J Soc Gynecol Investig 2004; 11: 193–202
   PubMedGoogle Scholar
• Madsen G, Zakar T, Ku C Y, Sanborn B M, Smith R, Mesiano S. Prostaglandins differentially modulate progesterone receptor-A and -B expression in human myometrial cells: Evidence for prostaglandin-induced functional progesterone withdrawal. J Clin Endocrinol Metab 2004; 89: 1010–1013
   PubMed Web of Science ®Google Scholar
• Ni X, Hou Y, Yang R, Tang X, Smith R, Nicholson R C. Progesterone receptors A and B differentially modulate corticotropin-releasing hormone gene expression through a cAMP regulatory element. Cell Mol Life Sci 2004; 61: 1114–1122
   PubMedGoogle Scholar
• Leite R S, Brown A G, Strauss J F, 3rd. Tumor necrosis factor-alpha suppresses the expression of steroid receptor coactivator-1 and -2: A possible mechanism contributing to changes in steroid hormone responsiveness. FASEB J 2004; 18: 1418–1420
   PubMedGoogle Scholar
• Leonhardt S A, Boonyaratanakornkit V, Edwards D P. Progesterone receptor transcription and non-transcription signaling mechanisms. Steroids 2003; 68: 761–770
   PubMed Web of Science ®Google Scholar
• Cermik D, Karaca M, Taylor H S. HOXA10 expression is repressed by progesterone in the myometrium: Differential tissue-specific regulation of HOX gene expression in the reproductive tract. J Clin Endocrinol Metab 2001; 86: 3387–3392
   PubMed Web of Science ®Google Scholar
• Stjernholm-Vladic Y, Wang H, Stygar D, Ekman G, Sahlin L. Differential regulation of the progesterone receptor A and B in the human uterine cervix at parturition. Gynecol Endocrinol 2004; 18: 41–46
   PubMed Web of Science ®Google Scholar
• Oh S Y, Kim C J, Park I, Romero R, Sohn Y K, Moon K C, Yoon B H. Progesterone receptor isoform (A/B) ratio of human fetal membranes increases during term parturition. Am J Obstet Gynecol 2005; 193: 1156–1160
   PubMedGoogle Scholar
• Norwitz E R, Wilson T. Secretory component: A potential regulator of endometrial-decidual prostaglandin production in early human pregnancy. Am J Obstet Gynecol 2000; 183: 108–117
   PubMed Web of Science ®Google Scholar
• Gibb W. The role of prostaglandins in human parturition. Ann Med 1998; 30: 235–241
   PubMed Web of Science ®Google Scholar
• Embrey M. PGE compounds for induction of labour and abortion. Ann N Y Acad Sci 1971; 180: 518–523
   PubMedGoogle Scholar
• Casey M L, MacDonald P C. Biomolecular processes in the initiation of parturition: Decidual activation. Clin Obstet Gynecol 1988; 31: 533–552
   PubMed Web of Science ®Google Scholar
• Allport V C, Pieber D, Slater D M, Newton R, White J O, Bennett P R. Human labour is associated with nuclear factor-kappaB activity which mediates cyclo-oxygenase-2 expression and is involved with the ‘functional progesterone withdrawal’. Mol Hum Reprod 2001; 7: 581–586
   PubMed Web of Science ®Google Scholar
• Loudon J A, Elliott C L, Hills F, Bennett P R. Progesterone represses interleukin-8 and cyclo-oxygenase-2 in human lower segment fibroblast cells and amnion epithelial cells. Biol Reprod 2003; 69: 331–337
   PubMed Web of Science ®Google Scholar
• Cakmak H, Schatz F, Huang S T, Buchwalder L, Rahman M, Arici A, Lockwood C J. Progestin suppresses thrombin- and interleukin-1beta-induced interleukin-11 production in term decidual cells: Implications for preterm delivery. J Clin Endocrinol Metab 2005; 90: 5279–5286
   PubMedGoogle Scholar
• Shields A D, Wright J, Paonessa D J, Gotkin J, Howard B C, Hoeldtke N J, Napolitano P G. Progesterone modulation of inflammatory cytokine production in a fetoplacental artery explant model. Am J Obstet Gynecol 2005; 193: 1144–1148
   PubMed Web of Science ®Google Scholar
• Elovitz M A, Mrinalini C. Can medroxyprogesterone acetate alter Toll-like receptor expression in a mouse model of intrauterine inflammation?. Am J Obstet Gynecol 2005; 193: 1149–1155
   PubMed Web of Science ®Google Scholar
• Wilson T, Liggins G C, Aimer G P, Skinner S J. Partial purification and characterisation of two compounds from amniotic fluid which inhibit phospholipase activity in human endometrial cells. Biochem Biophys Res Commun 1985; 131: 22–29
   PubMedGoogle Scholar
• Wilson T, Liggins G C, Joe L. Purification and characterization of a uterine phospholipase inhibitor that loses activity after labor onset in women. Am J Obstet Gynecol 1989; 160: 602–606
   PubMedGoogle Scholar
• Wilson T, Christie D L. Gravidin, an endogenous inhibitor of phospholipase A2 activity, is a secretory component of IgA. Biochem Biophys Res Commun 1991; 176: 447–452
   PubMedGoogle Scholar
• Wilson T, Ganendren R. Serum concentrations of secretory IgA in pregnancies delivering at term or preterm. Prostaglandins 1992; 44: 373–378
   PubMedGoogle Scholar
• Bennett W A, Allbert J R, Brackin M N, Morrison J C, Cowan B D. Secretory component in human amniotic fluid and gestational tissues: A potential endogenous phospholipase A2 inhibitor. J Soc Gynecol Investig 1999; 6: 311–317
   PubMedGoogle Scholar
• Henderson D, Wilson T. Reduced binding of progesterone receptor to its nuclear response element after human labor onset. Am J Obstet Gynecol 2001; 185: 579–585
   PubMed Web of Science ®Google Scholar
• Condon J C, Jeyasuria P, Faust J M, Wilson J W, Mendelson C R. A decline in the levels of progesterone receptor coactivators in the pregnant uterus at term may antagonize progesterone receptor function and contribute to the initiation of parturition. Proc Natl Acad Sci USA 2003; 100: 9518–9523
   PubMed Web of Science ®Google Scholar
• McLean M, Bisits A, Davies J, Woods R, Lowry P, Smith R. A placental clock controlling the length of human pregnancy. Nat Med 1995; 1: 460–463
   PubMed Web of Science ®Google Scholar
• Grammatopoulos D K, Hillhouse E W. Role of corticotropin-releasing hormone in onset of labour. Lancet 1999; 354: 1546–1549
   PubMed Web of Science ®Google Scholar
• Challis J R, Sloboda D M, Alfaidy N, Lye S J, Gibb W, Patel F A, Whittle W L, Newnham J P. Prostaglandins and mechanisms of preterm birth. Reproduction 2002; 124: 1–17
   PubMed Web of Science ®Google Scholar
• Karalis K, Goodwin G, Majzoub J A. Cortisol blockade of progesterone: A possible molecular mechanism involved in the initiation of human labor. Nat Med 1996; 2: 556–560
   PubMedGoogle Scholar
• Jeschke U, Mylonas I, Richter D U, Hocker I, Briese V, Makrigiannakis A, Friese K. Regulation of progesterone production in human term trophoblasts in vitro by CRH, ACTH and cortisol (prednisolone). Arch Gynecol Obstet 2005; 272: 7–12
   PubMedGoogle Scholar
• Grazzini E, Guillon G, Mouillac B, Zingg H H. Inhibition of oxytocin receptor function by direct binding of progesterone. Nature 1998; 392: 509–512
   PubMed Web of Science ®Google Scholar
• Thornton S, Terzidou V, Clark A, Blanks A. Progesterone metabolite and spontaneous myometrial contractions in vitro. Lancet 1999; 353: 1327–1329
   PubMedGoogle Scholar
• Astle S, Slater D M, Thornton S. The involvement of progesterone in the onset of human labour. Eur J Obstet Gynecol Reprod Biol 2003; 108: 177–181
   PubMed Web of Science ®Google Scholar
• Astle S, Khan R N, Thornton S. The effects of a progesterone metabolite, 5 beta-dihydroprogesterone, on oxytocin receptor binding in human myometrial membranes. Br J Obstet Gynaecol 2003; 110: 589–592
   Google Scholar
• Liu Z, Patino R. High-affinity binding of progesterone to the plasma membrane of Xenopus oocytes: Characteristics of binding and hormonal and developmental control. Biol Reprod 1993; 49: 980–988
   PubMed Web of Science ®Google Scholar
• Sabeur K, Edwards D P, Meizel S. Human sperm plasma membrane progesterone receptor(s) and the acrosome reaction. Biol Reprod 1996; 54: 993–1001
   PubMedGoogle Scholar
• Luconi M, Bonaccorsi L, Bini L, Liberatori S, Pallini V, Forti G, Baldi E. Characterization of membrane nongenomic receptors for progesterone in human spermatozoa. Steroids 2002; 67: 505–509
   PubMedGoogle Scholar
• Shah C, Modi D, Sachdeva G, Gadkar S, Puri C. Coexistence of intracellular and membrane-bound progesterone receptors in human testis. J Clin Endocrinol Metab 2005; 90: 474–483
   PubMed Web of Science ®Google Scholar
• Welter B H, Hansen E L, Saner K J, Wei Y, Price T M. Membrane-bound progesterone receptor expression in human aortic endothelial cells. J Histochem Cytochem 2003; 51: 1049–1055
   PubMed Web of Science ®Google Scholar
• Boonyaratanakornkit V, Edwards D P. Receptor mechanisms of rapid extranuclear signalling initiated by steroid hormones. Essays Biochem 2004; 40: 105–120
   PubMedGoogle Scholar
• Zhu Y, Bond J, Thomas P. Identification, classification, and partial characterization of genes in humans and other vertebrates homologous to a fish membrane progestin receptor. Proc Natl Acad Sci USA 2003; 100: 2237–2242
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists Committee on Obstetric Practice: Use of progesterone to reduce preterm birth. No. 291, November 2003.
   Google Scholar
• Gaspar R, Ducza E, Mihalyi A, Marki A, Kolarovszki-Sipiczki Z, Paldy E, Benyhe S, Borsodi A, Foldesi I, Falkay G. Pregnancy-induced decrease in the relaxant effect of terbutaline in the late-pregnant rat myometrium: Role of G-protein activation and progesterone. Reproduction 2005; 130: 113–122
   PubMedGoogle Scholar
• Chanrachakul B, Pipkin F B, Warren A Y, Arulkumaran S, Khan R N. Progesterone enhances the tocolytic effect of ritodrine in isolated pregnant human myometrium. Am J Obstet Gynecol 2005; 192: 458–463
   PubMed Web of Science ®Google Scholar